Current knowledge on irritable bowel syndrome treatment - literature overview
DOI:
https://doi.org/10.12775/JEHS.2024.67.55097Keywords
Irritable Bowel Syndrome, gut-brain axis, FODMAP diet, chronic gastrointestinal disorderAbstract
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and altered bowel habits. It affects a large proportion of the general population leading to a negative effect on the quality of life. The pathophysiology of IBS is not fully known. There are several therapies currently used in the treatment of IBS. They vary from changing dietary habits to antibiotic therapy and must be personalized.
References
Bonetto S, Fagoonee S, Battaglia E, et al. Recent advances in the treatment of irritable bowel syndrome. Pol Arch Intern Med. 2021; 131: 709-715. doi:10.20452/pamw.16067
Moayyedi P, Andrews CN, MacQueen G, Korownyk C, Marsiglio M, Graff L, Kvern B, Lazarescu A, Liu L, Paterson WG, Sidani S, Vanner S. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). J Can Assoc Gastroenterol. 2019 Apr;2(1):6-29. doi: 10.1093/jcag/gwy071. Epub 2019 Jan 17. PMID: 31294724; PMCID: PMC6507291.
Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014 Jun 14;20(22):6759-73. doi: 10.3748/wjg.v20.i22.6759. PMID: 24944467; PMCID: PMC4051916.
Galica AN, Galica R, Dumitrașcu DL. Diet, fibers, and probiotics for irritable bowel syndrome. J Med Life. 2022 Feb;15(2):174-179. doi: 10.25122/jml-2022-0028. PMID: 35419092; PMCID: PMC8999090.
Patel N, Shackelford K. Irritable Bowel Syndrome. [Updated 2022 Oct 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534810/
Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy. Front Microbiol. 2019 Jun 10;10:1136. doi: 10.3389/fmicb.2019.01136. Erratum in: Front Microbiol. 2019 Aug 13;10:1870. PMID: 31244784; PMCID: PMC6579922.
Sharma S, Kumar S, Sajjad S, Sharma S. Probiotics in Irritable Bowel Syndrome: A Review Article. Cureus. 2023 Mar 23;15(3):e36565. doi: 10.7759/cureus.36565. PMID: 37095805; PMCID: PMC10122169.
Su XT, Wang LQ, Zhang N, Li JL, Qi LY, Wang Y, Yang JW, Shi GX, Liu CZ. Standardizing and optimizing acupuncture treatment for irritable bowel syndrome: A Delphi expert consensus study. Integr Med Res. 2021 Sep;10(3):100728. Doi: 10.1016/j.imr.2021.100728. Epub 2021 Apr 24. PMID: 34307021; PMCID: PMC8296086.
Bellini M, Gambaccini D, Stasi C, Urbano MT, Marchi S, Usai-Satta P. Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol. 2014 Jul 21;20(27):8807-20. doi: 10.3748/wjg.v20.i27.8807. PMID: 25083055; PMCID: PMC4112881.
Shaikh SD, Sun N, Canakis A, Park WY, Weber HC. Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review. J Clin Med. 2023 Mar 28;12(7):2558. doi: 10.3390/jcm12072558. PMID: 37048642; PMCID: PMC10095554.
Boicean A, Birlutiu V, Ichim C, Anderco P, Birsan S. Fecal Microbiota Transplantation in Inflammatory Bowel Disease. Biomedicines. 2023 Mar 27;11(4):1016. doi: 10.3390/biomedicines11041016. PMID: 37189634; PMCID: PMC10135988.
Rodrigues T, Rodrigues Fialho S, Araújo JR, Rocha R, Moreira-Rosário A. Procedures in Fecal Microbiota Transplantation for Treating Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. J Clin Med. 2023 Feb 21;12(5):1725. doi: 10.3390/jcm12051725. PMID: 36902512; PMCID: PMC10003588.
Moshiree B, Heidelbaugh JJ, Sayuk GS. A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers. Adv Ther. 2022 Sep;39(9):4003-4020. doi: 10.1007/s12325-022-02224-z. Epub 2022 Jul 22. PMID: 35869354; PMCID: PMC9402521.
Savarino E, Zingone F, Barberio B, Marasco G, Akyuz F, Akpinar H, Barboi O, Bodini G, Bor S, Chiarioni G, Cristian G, Corsetti M, Di Sabatino A, Dimitriu AM, Drug V, Dumitrascu DL, Ford AC, Hauser G, Nakov R, Patel N, Pohl D, Sfarti C, Serra J, Simrén M, Suciu A, Tack J, Toruner M, Walters J, Cremon C, Barbara G. Functional bowel disorders with diarrhea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United European Gastroenterol J. 2022 Jul;10(6):556-584. doi: 10.1002/ueg2.12259. Epub 2022 Jun 13. PMID: 35695704; PMCID: PMC9278595.
Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP; TARGET Study Group. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011 Jan 6;364(1):22-32. doi: 10.1056/NEJMoa1004409. PMID: 21208106.
Moayyedi P, Andrews CN, MacQueen G, Korownyk C, Marsiglio M, Graff L, Kvern B, Lazarescu A, Liu L, Paterson WG, Sidani S, Vanner S. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). J Can Assoc Gastroenterol. 2019 Apr;2(1):6-29. doi: 10.1093/jcag/gwy071. Epub 2019 Jan 17. PMID: 31294724; PMCID: PMC6507291.
Camilleri, M. (1999), Review article: clinical evidence to support current therapies of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 13: 48-53. https://doi.org/10.1046/j.1365-2036.1999.00005.x-i2
Chapman, R W MD1; Stanghellini, V MD2; Geraint, M MB ChB3; Halphen, M MD3. Randomized Clinical Trial: Macrogol/PEG 3350 Plus Electrolytes for Treatment of Patients With Constipation Associated With Irritable Bowel Syndrome. American Journal of Gastroenterology 108(9):p 1508-1515, September 2013. | DOI: 10.1038/ajg.2013.197
Liu YL, Liu JS. Irritable bowel syndrome in China: a review on the epidemiology, diagnosis, and management. Chin Med J (Engl). 2021 Jun 1;134(12):1396-1401. doi: 10.1097/CM9.0000000000001550. PMID: 34074848; PMCID: PMC8213251.
Yang Y, Fang J, Guo X, Dai N, Shen X, Yang Y, Sun J, Bhandari BR, Reasner DS, Cronin JA, Currie MG, Johnston JM, Zeng P, Montreewasuwat N, Chen GZ, Lim S. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions. J Gastroenterol Hepatol. 2018 May;33(5):980-989. doi: 10.1111/jgh.14086. Epub 2018 Mar 12. PMID: 29319191.
Lacy BE, Patel NK. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J Clin Med. 2017 Oct 26;6(11):99. doi: 10.3390/jcm6110099. PMID: 29072609; PMCID: PMC5704116.
Hojo M, Nagahara A. Current perspectives on irritable bowel syndrome: a narrative review. J Int Med Res. 2022 Sep;50(9):3000605221126370. doi: 10.1177/03000605221126370. PMID: 36171718; PMCID: PMC9523849.
Xie C, Tang Y, Wang Y, Yu T, Wang Y, Jiang L, Lin L. Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis. PLoS One. 2015 Aug 7;10(8):e0127815. doi: 10.1371/journal.pone.0127815. PMID: 26252008; PMCID: PMC4529302.
Blanton N. The Gut-Brain Connection: How Psychotherapy Treats Irritable Bowel Syndrome. Baylor College of Medicine Blog Network. 2019 Jan 10. Available from: https://blogs.bcm.edu/2019/01/10/the-gut-brain-connection-how-psychotherapy-treats-irritable-bowel-syndrome/
Singh R, Salem A, Nanavati J, Mullin GE. The Role of Diet in the Treatment of Irritable Bowel Syndrome: A Systematic Review. Gastroenterol Clin N Am 2018; 47: 107-137.
Skodje GI, Sarna VK, Minelle IH, Rolfsen KL, Muir JG, Gibson PR, Veierød MB, Henriksen C, Lundin KEA. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology 2018; 154: 529.
Chen L, Ilham SJ, Feng B. Pharmacological Approach for Managing Pain in Irritable Bowel. Syndrome: A Review Article. Anesth Pain Med 2017; 7: e42747.
Matthew J. Plummer NT. Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis. Integrative Medicine 2015; 14: 25-33.
Sterm E. Brenner DM. Gut Microbiota-Based Therapies for Irritable Bowel Syndrome Clinical and Translational. Gastroenterology 2018; 9: e134.
Bedell, A. Keefer, L. (Adapted by A. Miller). Cognitive behavioral therapy for IBS and other functional gastrointestinal disorders (2021). International Foundation for Gastrointestinal Disorders. Available from: https://iffgd.org/wp-content/uploads/276-CBT-for-IBS-and-Other-FGIDs.pdf
Gonsalkorale W. M. Miller V. Afzal A. Whorwell P. J. Long-term benefits of hypnotherapy for irritable bowel syndrome. Gut. 2003 Nov;52(11):1623-9. Doi: 10.1136/gut.52.11.1623. PMID: 14570733; PMCID: PMC1773844.
Hulme K. Chilcot J. Smith MA. Doctor-patient relationship and quality of life in Irritable Bowel Syndrome: an exploratory study of the potential mediating role of illness perceptions and acceptance. Psychol Health Med. 2018 Jul;23(6):674-684. doi: 10.1080/13548506.2017.1417613. Epub 2017 Dec 20. PMID: 29260889.
Chen L. Ilham SJ. Feng B. Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article. Anesth Pain Med 2017; 7: e42747.
O’Sullivan M. Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum. Gut 2011; 60: 423
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ilona Jasiuk, Kamil Chrościński, Ewa Łukaszewska, Ilona Sajkiewicz, Nadia Miga-Orczykowska, Paulina Lemieszek, Justyna Wójtowicz, Katarzyna Krukar, Martyna Pustelniak, Klaudia Kister, Jakub Laskowski, Katarzyna Rudnicka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 120
Number of citations: 0
